NCT01712880

Brief Summary

The purpose of this study is to determine the success rate of two treatments for infection after total hip replacement: single stage arthroplasty exchange (your surgeon will take out your original implants and replace them with a complete new set) compared to irrigation and debridement with modular exchange (your surgeon will clean your implants with a surgical solution and take out the plastic liner and replace it with a new one - the rest of your hip implants will stay in place). The goal is to see if one is better than the other for the treatment of hip infection after a total hip replacement. A successful treatment means that you did not have to have another surgery on your hip for an infection-related reason.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 24, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 6, 2013

Status Verified

November 1, 2013

Enrollment Period

1.1 years

First QC Date

October 22, 2012

Last Update Submit

November 5, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success

    Success is defined as no subsequent revision surgery needed to treat chronic or acute periprosthetic infection

    2 year

Study Arms (2)

open debridement with modular exchange

ACTIVE COMPARATOR
Procedure: open debridement with modular exchange

one stage exchange

ACTIVE COMPARATOR
Procedure: one stage exchange

Interventions

open debridement with modular exchange
one stage exchange

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Return to the OR for a drainage procedure within six weeks of index primary uncemented arthroplasty 1a) Exam findings within six weeks of index operation:
  • Drainage for more than 7 days
  • Wound appearance consistent with deep infection or hematoma
  • Persistent fever or evidence of bacteremia
  • All patients currently deemed appropriate for irrigation and debridement
  • Labs
  • \- Rising inflammatory seromarkers
  • Aspiration with a positive culture

You may not qualify if:

  • Previous history of periprosthetic infection
  • Prisoners
  • Patients not willing to consent for the proposed treatment
  • Patients with altered mental status
  • Concurrent metastatic infection
  • Superficial Infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OrthoCarolina Research Institue

Charlotte, North Carolina, 28207, United States

Location
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2012

First Posted

October 24, 2012

Study Start

October 1, 2012

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 6, 2013

Record last verified: 2013-11

Locations